-
1
-
-
33646559664
-
-
American Cancer Society. American Cancer Society, Inc.
-
American Cancer Society: Cancer Facts & Figures 2006. American Cancer Society, Inc. 2006
-
(2006)
Cancer Facts & Figures 2006
-
-
-
3
-
-
33750684420
-
The association between fibrinogen, von Willebrand factor, antithrombin III, and D-dimer levels and survival outcome by 36 months from ovarian cancer
-
S. C. L. Koh, R. Khalil, F. -K. Lim, A. Ilancheran, M. Choolani: The association between fibrinogen, von Willebrand Factor, Antithrombin III, and D-Dimer levels and survival outcome by 36 months from ovarian cancer. Clin Appl Thrombosis/Hemostasis. 11(3) (2005) T1-T6
-
(2005)
Clin Appl Thrombosis/Hemostasis
, vol.11
, Issue.3
-
-
Koh, S.C.L.1
Khalil, R.2
Lim, F.K.3
Ilancheran, A.4
Choolani, M.5
-
4
-
-
0030028943
-
Preoperative evaluation of D-dimer and CA 125 levels in differentiating benign from malignant ovarian masses
-
A. Gadducci, U. Baicchi, R. Marrai, M. Ferdeghini, R. Bianchi, V. Facchini: Preoperative evaluation of D-Dimer and CA 125 levels in differentiating benign from malignant ovarian masses. Gynecologic Oncology. 60 (1996) 197-202
-
(1996)
Gynecologic Oncology
, vol.60
, pp. 197-202
-
-
Gadducci, A.1
Baicchi, U.2
Marrai, R.3
Ferdeghini, M.4
Bianchi, R.5
Facchini, V.6
-
5
-
-
0035081799
-
Hemostatic and fibrinolytic status in patients with ovarian cancer and benign ovarian cysts: Could D-dimer and antithrombin III levels be included as prognostic markers for survival outcome?
-
S. C. L. Koh, K. -F. Tham, R. Khalil, P. -L. Oei, F. -K. Lim, A. -C. Roy, R. N. V. Prasad: Hemostatic and fibrinolytic status in patients with ovarian cancer and benign ovarian cysts: could D-Dimer and antithrombin III levels be included as prognostic markers for survival outcome? Clin Appl Thrombosis/Hemostasis. 7(2) (2001) 141-148
-
(2001)
Clin Appl Thrombosis/Hemostasis
, vol.7
, Issue.2
, pp. 141-148
-
-
Koh, S.C.L.1
Tham, K.F.2
Khalil, R.3
Oei, P.L.4
Lim, F.K.5
Roy, A.C.6
Prasad, R.N.V.7
-
6
-
-
0031193381
-
Preoperative D-dimer plasma assay is not a predictor of clinical outcome for patients with advanced ovarian cancer
-
A. Gadducci, R. Marrai, U. Baicchi, M. Ferdeghini, A. Fanucchi, C. Weiss, A. R. Genazzani: Preoperative D-Dimer plasma assay is not a predictor of clinical outcome for patients with advanced ovarian cancer. Gynecologic Oncology. 66 (1997) 85-88
-
(1997)
Gynecologic Oncology
, vol.66
, pp. 85-88
-
-
Gadducci, A.1
Marrai, R.2
Baicchi, U.3
Ferdeghini, M.4
Fanucchi, A.5
Weiss, C.6
Genazzani, A.R.7
-
7
-
-
27744447007
-
Ovarian cancer diagnosis by hippocampus and neocortexinspired learning memory structures
-
T. Z. Tan, C. Quek, G. S. Ng: Ovarian cancer diagnosis by hippocampus and neocortexinspired learning memory structures. Neural Networks. 18(5-6) (2005) 818-825
-
(2005)
Neural Networks
, vol.18
, Issue.5-6
, pp. 818-825
-
-
Tan, T.Z.1
Quek, C.2
Ng, G.S.3
-
8
-
-
0036833706
-
Contextual control of stimulus generalization and stimulus equivalence in hierarchical categorization
-
K. Griffee, M. J. Dougher: Contextual control of stimulus generalization and stimulus equivalence in hierarchical categorization. Journal of the Experimental Analysis of Behavior. 78(3) (2002) 433-447
-
(2002)
Journal of the Experimental Analysis of Behavior
, vol.78
, Issue.3
, pp. 433-447
-
-
Griffee, K.1
Dougher, M.J.2
-
9
-
-
33750692090
-
Systemic prognostic haemostatic marker levels for disease outcome within five years from ovarian cancer
-
S. C. L. Koh, R. Khalil, M. Choolani, A. Ilancheran: Systemic prognostic haemostatic marker levels for disease outcome within five years from ovarian cancer. Journal of Thrombosis and Haemostasis. 3 (suppl. 1) (2005) P1314
-
(2005)
Journal of Thrombosis and Haemostasis
, vol.3
, Issue.SUPPL. 1
, pp. 1314
-
-
Koh, S.C.L.1
Khalil, R.2
Choolani, M.3
Ilancheran, A.4
-
10
-
-
0029959998
-
Prothrombin fragment F1+2 and thrombin-antithrombin III complex (TAT) plasma levels in patients with gynecological cancer
-
A. Gadducci, R. Marrai, U. Baicchi, O. Gagetti, V. Facchini, A. R. Genazzni: Prothrombin fragment F1+2 and thrombin-antithrombin III complex (TAT) plasma levels in patients with gynecological cancer. Gynecologic Oncology. 61 (1996) 215-217
-
(1996)
Gynecologic Oncology
, vol.61
, pp. 215-217
-
-
Gadducci, A.1
Marrai, R.2
Baicchi, U.3
Gagetti, O.4
Facchini, V.5
Genazzni, A.R.6
-
11
-
-
33645288318
-
Role of tissue factor in hemostasis and thrombosis
-
in press
-
N. Mackman: Role of tissue factor in hemostasis and thrombosis. Blood Cells, Molecules, and Diseases. (2006) in press.
-
(2006)
Blood Cells, Molecules, and Diseases
-
-
Mackman, N.1
|